Financial Sense Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Financial Sense Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-65,509	Closed	-$4.09M	–	74
2018 Q1	$4.09M	Buy	65,509 +30,144	+85%	+$1.98M	1.98%	13
2017 Q4	$2.27M	Buy	35,365 +12,421	+54%	+$796K	1.05%	19
2017 Q3	$1.5M	Buy	22,944 +1,131	+5%	+$71.4K	0.77%	25
2017 Q2	$1.37M	Buy	+21,813	New	+$1.31M	0.72%	26

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Financial Sense Advisors's PJP Position: Q2 2018 in Review

Financial Sense Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 65,509 shares — an estimated $4.09M sold.

Financial Sense Advisors first reported a position in PJP in Q2 2017 and held it in 4 quarters. The position peaked at $4.09M in Q1 2018. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Financial Sense Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Financial Sense Advisors sold 65,509 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $4.09M.
Financial Sense Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2017 and held it in 4 quarters.
Financial Sense Advisors's Invesco Pharmaceuticals ETF position peaked at $4.09M in Q1 2018.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Financial Sense Advisors's 13F filing for Q2 2018, filed 26 Jul 2018.